Boiron SA (BOI) - Strategic SWOT Analysis Review

June 2018 | 28 pages | ID: B41EEB22C4EEN
GlobalData

Abstracts

Boiron SA (BOI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Boiron SA (Boiron) is a pharmaceutical company that develops, manufactures and commercializes homeopathic medicines. The company manufactures its products through vegetable, animal, mineral or chemical origins. Its product portfolio comprises Camilia, Arnigel, Oscillococcinum, HomeovoX, Sedatif PC, Coryzalia, Arnicalme, Homeoptic and Stodal. Boiron’s products are used for the treatment of fever, chills, headaches, aches, coughs, muscle fatigue, bruising, contusions and others. The company has operational presence in Western Europe, Central Eastern and Europe and North America. It also manages production facilities in France and Belgium. Boiron is headquartered in Sainte-Foy-les-Lyon, France.

Boiron SA Key Recent Developments

Mar 14,2018: BOIRON: 2017 results
Sep 07,2017: BOIRON: 2017 half year results
Jul 20,2017: Boiron: 2017 Half-year Activity

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Boiron SA - Key Facts
Boiron SA - Key Employees
Boiron SA - Key Employee Biographies
Boiron SA - Major Products and Services
Boiron SA - History
Boiron SA - Company Statement
Boiron SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Boiron SA - Business Description
Business Segment: Non-Proprietary Homeopathic Medicines
Overview
Performance
Business Segment: OTC Specialties
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Europe excluding France
Performance
Geographical Segment: France
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Countries
Performance
Boiron SA - SWOT Analysis
SWOT Analysis - Overview
Boiron SA - Strengths
Boiron SA - Weaknesses
Boiron SA - Opportunities
Boiron SA - Threats
Boiron SA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Boiron SA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Mar 14, 2018: BOIRON: 2017 results
Sep 07, 2017: BOIRON: 2017 half year results
Jul 20, 2017: Boiron: 2017 Half-year Activity

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Boiron SA, Key Facts
Boiron SA, Key Employees
Boiron SA, Key Employee Biographies
Boiron SA, Major Products and Services
Boiron SA, History
Boiron SA, Subsidiaries
Boiron SA, Key Competitors
Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Boiron SA, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Boiron SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Virbac Group
The Nature’s Bounty Co
Nelson & Co Ltd
Biologische Heilmittel Heel GmbH
Arkopharma Laboratories SA